Professional Documents
Culture Documents
ANALYSIS
DIKSHITHA S
GANGOTHRI T
GAZALA AFREEN
N PRAGATHI
NOORI MOHAMADI
PRIYANKA R
THILAKAVATHI M
UNILEVER
• Unilever is a British-Dutch transnational consumer goods company co-
headquartered in London, United Kingdom and Rotterdam, Netherlands .
Its products include food and beverages (about 40 per cent of its revenue),
cleaning agents, beauty products, and personal care products. It is
Europe’s seventh most valuable company. Unilever is one of the oldest
multinational companies; its products are available in around 190
countries.
• Unilever owns over 400 brands, with a turnover in 2017 of 53.7 billion
euros, and thirteen brands with sales of over one billion euros: Axe/Lynx,
Dove, Omo, Heartbrand ice creams, Hellmann's, Knorr, Lipton, Lux,
Magnum, Rexona/Degree, Sunsilk and Surf . It is a dual-listed company
consisting of Unilever plc, based in London, and Unilever N.V., based in
Rotterdam. The two companies operate as a single business, with a
common board of directors. Unilever is organised into four main divisions
– Foods, Refreshment (beverages and ice cream), Home Care, and Beauty
& Personal Care. It has research and development facilities in the United
Kingdom (two), the Netherlands, China, India and the United States.
Hindustan Unilever Limited (HUL) is a British-Dutch company headquartered in
Mumbai, Maharashtra . Its products include foods, beverages, cleaning agents,
personal care products, water purifiers and consumer goods.
HUL was established in 1933 as Lever Brothers. Following the merger among Lever
Brothers in 1956, it was renamed as Hindustan Lever Limited. The company was
renamed in June 2007 as "Hindustan Unilever Limited".
As of 2019 HUL portfolio had 35 product brands in 20 categories and employs
18,000 employees with sales of Rs. 34,619 crores in 2017-18.
In December 2018, HUL announced its acquisition of Glaxo Smithkline’s India
business for $3.8 billion in an all equity merger deal with 1:4.39 ratio. However
the integration of 3800 employees of GSK remained uncertain as HUL stated there
was no clause for retention of employees in the deal. In January 2019, HUL said
that it expects to complete the merger with Glaxo Smith Kline Consumer
Healthcare (GSKCH India) this year.
TURNOVER = 50982 EURO MILLION
20%
BEAUTY AND
40% PERSONAL CARE
FOODS AND
REFRESHMENT
HOME CARE
40%
CONSOLIDATED INCOME
STATEMENTS
PARTICULARS 31st March 31st March 31st March 31st March 31st March
2014 2015 2016 2017 2018
Turnover 48436 53272 52713 53715 50982
Operating profit 7980 7515 7801 8857 12535
After (charging)/crediting non-underlying 960 (796) (823) (543) 3175
items
Net finance costs (477) (493) (563) (877) (481)
Net monetary gain/(loss) arising from - - - - 122
hyperinflationary economies
Share of net profit/(loss) of joint ventures and 98 107 127 155 185
associates
After crediting non underlying items - - - - 32
Other income/(loss)from non current 45 91 104 18 22
investments and associates
Profit before taxation 7646 7220 7469 8153 12383
Taxation (2131) (1961) (1922) (1667) (2575)
After (charging)/crediting tax impact of non - 180 213 655 (288)
underlying items
Net profit 5515 5259 5547 6486 9808
Attributable to :
Non – controlling interests 344 350 363 433 419
Shareholders’ equity 5171 4909 5184 6053 9389
Combined earnings per share
Basic earnings per share 1.82 1.73 1.83 2.16 3.5
Diluted earnings per share 1.79 1.72 1.82 2.15 3.48
TURNOVER
55000 53272 53715
52713
50982
50000 48436
TURNOVER
45000
2014 2015 2016 2017 2018
PERCENTAGE CHANGE 2014 & 15 2015 & 16 2016 & 17 2017 & 18 2014 & 18
(INCREASE/DECREASE)
9.98% (1.04)% 1.9% (5.08)% 5.25 %
OPERATING PROFIT
15000 12535
10000 7980 7801 8857
7515
5000 OPERATING PROFIT
0
2014 2015 2016 2017 2018
PERCENTAGE CHANGE 2014 & 15 2015 & 16 2016 & 17 2017 & 18 2014 & 18
(INCREASE/DECREASE)
(5.82)% 3.80% 13.53% 41.52% 57.08%
NET PROFIT
12000
9808
10000
8000
6486
6000 5515 5259 5547
NET PROFIT
4000
2000
0
2014 2015 2016 2017 2018
PERCENTAGE CHANGE 2014 & 15 2015 & 16 2016 & 17 2017 & 18 2014 & 18
(INCREASE/DECREASE)
(4.64)% 5.47% 16.92% 51.21% 77.84%
OPERATING PROFIT RATIO
LIABILITIES
Current Liabilities
Non-current Liabilities
EQUITY
Shareholders Equity
PERCENTAGE CHANGE 2014 & 15 2015 & 16 2016 & 17 2017 & 18 2014 & 18
(INCREASE/DECREASE) 11.02 % 7.40 % 1.77 % 1.55 % 23.24 %
CURRENT ASSETS
18000 16983
16000 15481
13884
14000 12686
12347
12000
10000
8000
6000
4000
2000
0
2014 2015 2016 2017 2018
CURRENT ASSETS
PERCENTAGE CHANGE 2014 & 15 2015 & 16 2016 & 17 2017 & 18 2014 & 18
(INCREASE/DECREASE) 2.74 % 9.44 % 22.32 % (8.84) % 25.38 %
CURRENT LIABILITIES
24000
23177
23000
22000
21000 20556
20019
20000 19642 19772
19000
18000
17000
2014 2015 2016 2017 2018
CURRENT LIABILITIES
PERCENTAGE CHANGE 2014 & 15 2015 & 16 2016 & 17 2017 & 18 2014 & 18
(INCREASE/DECREASE) 1.91 % 2.68 % 12.75 % (14.69) % 0.66 %
NON CURRENT LIABILITIES
30000
27392
25000 22721
20000 18893
16197
15000 14121
10000
5000
0
2014 2015 2016 2017 2018
NON CURRENT LIABILITIES
PERCENTAGE CHANGE 2014 & 15 2015 & 16 2016 & 17 2017 & 18 2014 & 18
(INCREASE/DECREASE) 14.70 % 16.64 % 20.26 % 20.55 % 93.98 %
EQUITY
18000 16980
16082
16000
14263 14387
14000
12292
12000
10000
8000
6000
4000
2000
0
2014 2015 2016 2017 2018
EQUITY
PERCENTAGE CHANGE 2014 & 15 2015 & 16 2016 & 17 2017 & 18 2014 & 18
(INCREASE/DECREASE) 12.75 % 5.58 % (15.27) % (14.56) % (13.81) %
CURRENT RATIO
PROPRIETORY RATIO